Brief: Emmaus Life Sciences Announces Engagement Of Partner International To Lead Out-Licensing Of Endari For Diverticulosis
16/07/2020 13:16
July 16 (Reuters) - Emmaus Life Sciences Inc EMMA.PK :
* EMMAUS LIFE SCIENCES ANNOUNCES ENGAGEMENT OF PARTNER
INTERNATIONAL TO LEAD OUT-LICENSING OF ENDARI® FOR
DIVERTICULOSIS
Source text for Eikon: ID:nGNX1N3Gnc
Further company coverage: EMMA.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns